511 related articles for article (PubMed ID: 19588183)
1. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
Zhao Y; Chen X; Cai L; Yang Y; Sui G; Fu S
J Cell Physiol; 2010 Oct; 225(1):168-73. PubMed ID: 20458733
[TBL] [Abstract][Full Text] [Related]
3. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
4. Beta-arrestin 2 mediates cardiac hypertrophy induced by thyroid hormones via AT1R.
Lino CA; de Bortoli Teixeira L; Capelupe Simões S; de Oliveira Silva T; Diniz GP; da Costa-Neto CM; Barreto-Chaves MLM
J Cell Physiol; 2021 Jun; 236(6):4640-4654. PubMed ID: 33345322
[TBL] [Abstract][Full Text] [Related]
5. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL
Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255
[TBL] [Abstract][Full Text] [Related]
6. Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor.
Diniz GP; Lino CA; Guedes EC; Moreira Ldo N; Barreto-Chaves ML
Basic Res Cardiol; 2015 Sep; 110(5):49. PubMed ID: 26202011
[TBL] [Abstract][Full Text] [Related]
7. G Protein-Coupled Estrogen Receptor 1 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy via the Regulation of PI3K-Akt-mTOR Signalling and Autophagy.
Pei H; Wang W; Zhao D; Su H; Su G; Zhao Z
Int J Biol Sci; 2019; 15(1):81-92. PubMed ID: 30662349
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes.
Kuzman JA; Gerdes AM; Kobayashi S; Liang Q
J Mol Cell Cardiol; 2005 Nov; 39(5):841-4. PubMed ID: 16171808
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
Kang BY; Mehta JL
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
[TBL] [Abstract][Full Text] [Related]
10. Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3beta signaling pathway.
Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
Peptides; 2010 Jul; 31(7):1326-33. PubMed ID: 20416349
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways.
Kenessey A; Ojamaa K
J Biol Chem; 2006 Jul; 281(30):20666-20672. PubMed ID: 16717100
[TBL] [Abstract][Full Text] [Related]
12. A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.
Lyu L; Wang H; Li B; Qin Q; Qi L; Nagarkatti M; Nagarkatti P; Janicki JS; Wang XL; Cui T
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):268-79. PubMed ID: 26497614
[TBL] [Abstract][Full Text] [Related]
13. KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.
Liou SF; Hsu JH; Chen YT; Chen IJ; Yeh JL
Molecules; 2015 Jun; 20(6):10435-49. PubMed ID: 26056815
[TBL] [Abstract][Full Text] [Related]
14. Triiodothyronine (T3) induces proinsulin gene expression by activating PI3K: possible roles for GSK-3β and the transcriptional factor PDX-1.
Goulart-Silva F; Serrano-Nascimento C; Texeira SS; Nunes MT
Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):14-9. PubMed ID: 23147208
[TBL] [Abstract][Full Text] [Related]
15. AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes.
Takano APC; Senger N; Munhoz CD; Barreto-Chaves MLM
Pflugers Arch; 2018 Mar; 470(3):549-558. PubMed ID: 29178049
[TBL] [Abstract][Full Text] [Related]
16. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
Javadov S; Rajapurohitam V; Kilić A; Zeidan A; Choi A; Karmazyn M
J Mol Cell Cardiol; 2009 Jun; 46(6):998-1007. PubMed ID: 19318234
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy.
Shanmugam P; Valente AJ; Prabhu SD; Venkatesan B; Yoshida T; Delafontaine P; Chandrasekar B
J Mol Cell Cardiol; 2011 Jun; 50(6):928-38. PubMed ID: 21376054
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
Kuzman JA; O'Connell TD; Gerdes AM
Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
[TBL] [Abstract][Full Text] [Related]
19. Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
Kang BY; Khan JA; Ryu S; Shekhar R; Seung KB; Mehta JL
J Cardiovasc Pharmacol; 2010 Apr; 55(4):417-24. PubMed ID: 20422739
[TBL] [Abstract][Full Text] [Related]
20. AT1R/GSK-3
Si W; Li B; Lenahan C; Li S; Gu R; Qu H; Wang L; Liu J; Tian T; Wang Q; XikeWang ; Hu X; Zuo G
Oxid Med Cell Longev; 2020; 2020():8864323. PubMed ID: 33425219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
